Alternatives to Surf Therapeutics

Medical technology company developing bio-integrative, metal-free orthopedic fixation implants for natural bone healing.

Biotech company developing targeted regenerative therapeutics using a proprietary protein engineering platform for tissue repair.

Developing implantable neuroimmune modulation therapies to treat chronic autoimmune diseases like rheumatoid arthritis.

Revolutionizing genomic analysis with innovative sequencing technology.

Pioneering vision restoration therapies for severe retinal degenerations.

Develops and distributes bioreactor technology for stem cell cultivation.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

Global supplier of life science research tools, including antibodies, reagents, and assays.

A vertically-integrated procurement platform for the life sciences industry.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

A global leader in clinical pharmacology and bioanalytical sciences.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

AI-powered knowledge discovery for life sciences.

Biotechnology company developing plant-based biomaterials for regenerative medicine and tissue engineering.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

Biotechnology startup using genetically engineered insects to convert organic waste into high-value recombinant proteins.

AI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.

Developing ultrasound-mediated nonviral genetic medicines.

A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology.

Developing advanced vision restoration technology through a retinal implant.

Developing a new generation of molecular diagnostics for at-home use, combining laboratory accuracy with rapid test simplicity.

Developing lightweight bionic technology.

Developing a novel therapeutic approach for Alzheimer's disease.

Wilbe provides flexible lab infrastructure and services for science startups.

Unlocking industrial-scale RNA-seq for primary drug screening and toxicology.

NeuroTech company developing therapies to restore movement and independence for people with spinal cord injuries.

Clinical-stage pharmaceutical company developing innovative oral therapies for diabetes and metabolic disorders.

Developing soft, stretchable brain-computer interface platforms.

Developing microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health.

Developing novel male contraceptives.

Platform designed to cut cell and gene therapy production costs.

Developing a new histotripsy therapeutic platform for cancer treatment.

AI-enabled technology for cell biology research and biopharma development.

A leading incubator and venture builder in deep tech and life science.

AI-driven biotechnology company developing novel protein therapeutics through generative biology.

Elevating uterine health through innovative biomaterial therapies.

Clinical-stage biopharmaceutical company developing novel boron-based small molecule therapeutics for rare infectious diseases and oncology.

Developing and manufacturing laminin-based cell culture substrates for advanced cell therapies and drug discovery.

Develops multimodal hemoadsorption therapeutic devices for sepsis and septic shock.

Biopharmaceutical company developing best-in-class medicines for autoimmune and rare diseases, with a focus on thyroid eye disease.

Developing novel therapeutics for inflammatory and hypoxic diseases.

Optimizing the delivery and efficacy of cancer therapeutics through hyperthermic intravesical chemotherapy.

A biotech spin-out from the University of Edinburgh developing novel bioprocessing solutions.

Developing human microbiology models for drug discovery.

Global transport technology for living cells.

Developing breath-based diagnostics for lung diseases.

A clinical-stage dermatology company developing novel therapies for inflammatory skin diseases.

Empowering pharmaceutical researchers with advanced molecular understanding.

Epitel develops AI-driven wireless brain health technologies for remote EEG monitoring, improving diagnosis and management of neurological conditions like epilepsy.

Ophthalmology-focused biopharmaceutical company developing sustained-release drug delivery systems for serious eye diseases.

Revolutionizing the treatment of thromboembolic disease through innovative medical technology and connected care solutions.